Author(s)

ZhiQiang Su, JunYang Zhao, YunWei Wang, QingXin Zhang, XinYu Ren, Han Meng, Lei Liu^*

Affiliation(s)

College of Integrated Traditional Chinese and Western Medicine, Jining Medical University, Jining 272076, Shandong, China.

Corresponding Author

Lei Liu

ABSTRACT

The pathogenesis of breast cancer is complex and the treatment strategies are diverse, but it still faces many challenges. The current surgery, radiotherapy and chemotherapy and other treatment methods have different disadvantages and limitations, so it is urgent to find a safer and more effective treatment methods. Traditional Chinese medicine (TCM) has rich experience in clinical prevention and treatment, and TCM prescriptions can inhibit breast cancer metastasis, prevent and treat postoperative complications, and improve the quality of life of patients. To study the mechanism of jieyuxiaozheng granule in the prevention and treatment of breast cancer, to provide theoretical support for its wide clinical application, and to help to bring safer and more effective treatment plans for breast cancer patients.

KEYWORDS

Jieyuxiaozheng granule; Breast cancer; Liver-qi depression; Traditional Chinese medicine

CITE THIS PAPER

ZhiQiang Su, JunYang Zhao, YunWei Wang, QingXin Zhang, XinYu Ren, Han Meng, Lei Liu. Preliminary study on the mechanism of jieyu xiaozheng granule in the prevention and treatment of breast cancer. Journal of Pharmaceutical and Medical Research. 2024, 6(3): 45-47. DOI: 10.61784/jpmr3015.

REFERENCES

[1] LI Xiaoyu, HUANG Qing, WU Yumeng, et al. The Global Cancer Statistics Report in 2022: A Narrow Spectrum Summary and Outlook. Cancer Research on Prevention and Treatment, 2024, 51(5): 307.

[2] GU Yu, WU Mianhua. Clinical experience of TCM master ZHOU Zhong-ying in treating breast cancer. China Journal of Traditional Chinese Medicine and Pharmacy, 2020, 35(10): 4.

[3] Zou JH, Xiao ZH, Wu Jiao, et al. Wu Yu's experience in the treatment of breast cancer by applying the theory of “qi yu sheng yan”. Guiding Journal of Traditional Chinese Medicine and Pharmacy, 2021, 27(08): 182-184.

[4] SANG Yiting, LI Jie. Clinical experience of Li Jin treating breast cancer using liver-expelling and spleen-strengthening methods. Journal of Basic Chinese Medicine, 2020, 26(6): 3.

[5] WANG Liqin, TANG Xiaoling, GUO Jian, et al. Exploring the theoretical origin of the treatment of breast cancer with the addition and subtraction of Chaihu Shuohe San. Practical Clinical Journal of Integrated Traditional Chinese and Western Medicine, 2020, 20(07): 111-112+146.

[6] Consensus on combined Chinese and Western medicine diagnosis and treatment of breast cancer. Chinese Journal of the Frontiers of Medical Science (Electronic Version), 2021, 13(07): 44-64.

[7] LIU Yi-Ming, LI Qiu-Hua, LIANG Li-Che, et al. Pathogenesis and Treatment of Intermingled Phlegm and Blood Stasis in Breast Cancer. World Journal of Traditional Chinese Medicine, 2021, 16(21): 3127-3130.

[8] DONG Arjukhan, SI Zhiqiang, ZHANG Ying. Investigation of Therapeutic Mechanism of Chaihu Shugan Powder for the Treatment of Breast Cancer Based on Network Pharmacology. Journal of Oncology in Chinese Medicine, 2020, 2(02): 24-32+74.

[9] LIU Lei, NI Yi, YIN Fei. Efficacy of Chaihu Shuohe San plus reduction combined with CAF regimen in the treatment of stage III breast cancer and its effect on serum MMPs, estrogen levels and tumor markers. Chinese herbal medicine, 2020, 43(01): 220-223.

[10] LI Yang, BU Shuai, HAN Chao, et al. Exploration of the mechanism of action of network pharmacology-based antidepressant and elimination granules in the treatment of breast cancer. Journal of Chinese Medicinal Materials, 2022, 20(24): 1386-1392.

[11] JIANG Rongfei, YANG Zhihua, LIU Yan, et al. Analysis of Prescription Rules for Treatment of Breast Cancer by Fang Wenyan Based on Data Mining. Journal of Yunnan University of Traditional Chinese Medicine, 2019, 42(05): 75-80.

[12] Feng JX, Wu XX, Chen JH, et al. Saikosaponin D inhibits proliferation and promotes apoptosis in breast cancer cells through down-regulating JAK2 /STAT3 pathway. Journal of Third Military Medical University, 2021, 43(09): 852-857.

[13] WANG Bing, SUN Tao. Effects of Chaihu saponin D on proliferation and apoptosis of human breast cancer SK-BR-3 cell line. HENAN TRADITIONAL CHINESE MEDICINE, 2020, 40(05): 735-737.

[14] LUO Yan, JIANG Yilan, LI Yongmin, et al. Effects of Saikosaponin D on the Proliferation, Cell Cycle and the Expressions of Cyclins in Breast Cancer MDA-MB-231 Cells. Chinese Journal of Integrated Traditional and Western Medicine, 2019, 39(05): 572-576.

[15] LI Han, WU Kangxiong, SHI Kuohao, et al. Research progress on chemical constituents, pharmacological activities and clinical application of Bolbostemma paniculatum. China Journal of Chinese Materia Medica, 2021, 46(17): 4314-4322.

[16] LIU Fu-Feng, ZHANG Ya-Wei, SUN Yuan-Yuan, et al. Effects of tubeimoside-1 on proliferation, apoptosis, and autophagy of breast cancer MDA-MB-231 cells. Shandong Medical Journal, 2019, 59(20): 14-17.

[17] ZHANG Qinxiang, WEI Shijie, SUN Changgang. Turpentine A inhibits the proliferation, migration and invasive ability of triple-negative breast cancer cells through AKT/NF-κB signaling pathway. Beijing Journal of Traditional Chinese Medicine, 2024, 43(01): 23-26.

[18] DONG Jing, WANG Bangcai, SHI Hang. Clinical observation on the treatment of advanced triple-negative breast cancer with compound earth shellfish preparation combined with chemotherapy. Zhejiang Journal of Integrated Traditional Chinese and Western Medicine, 2019, 29(03): 203-205.

[19] Zhou Bo, Zhou Xia. Discussion on effects and mechanisms of telocinobufagin on inhibiting the proliferation of breast cancer cells by regulating signal transduction pathways related to the synthesis of MMP-2,MMP-9. Zhong Guo Shequyishi, 2020, 36(05): 4+6.